2-甲基-6-(苯基乙炔基)吡啶盐酸盐
2-甲基-6-(苯基乙炔基)吡啶盐酸盐 性质
| 熔点 | 145-146℃ |
|---|---|
| 储存条件 | room temp |
| 溶解度 | 二甲基亚砜：10 毫克/毫升 |
| 形态 | 固体 |
| 颜色 | 米白色 |
| 稳定性 | 自购买之日起 1 年内保持稳定。 DMSO 或乙醇溶液可在 -20°C 下保存长达 1 个月。 |
| InChI | 1S/C14H11N.ClH/c1-12-6-5-9-14(15-12)11-10-13-7-3-2-4-8-13;/h2-9H,1H3;1H |
| InChIKey | PKDHDJBNEKXCBI-UHFFFAOYSA-N |
| SMILES | Cl.Cc1cccc(n1)C#Cc2ccccc2 |
2-甲基-6-(苯基乙炔基)吡啶盐酸盐 用途与合成方法
|
mGluR5 36 nM (IC 50 ) |
MPEP does not show agonist or antagonist activity at 100 mM on human mGlu2, -3, -4a, -7b, and -8a receptors nor at 10 μM on the human mGlu6 receptor.
MPEP (1-30 mg/kg) induces anxiolytic-like effects in the conflict drinking test and the elevated plus-maze test in rats as well as in the four-plate test in mice.
MPEP (1-20 mg/kg) does shorten the immobility time in a tail suspension test in mice, however it is inactive in the behavioural despair test in rats.
MPEP (30 mg/kg i.p.) slightly but significantly increases (by 39%) the number of punished crossings in the four-plate test, lower doses of the compound (3 and 10 mg/kg) does not affect the number of punished crossings in that test (F (3,36)=3.240, P<0.05).
MPEP (1, 10 and 20 mg/kg) significantly (by 55% after the highest dose), (F(3,28)=15.47, P<0.001) decreases the immobility time of mice in the tail suspension test. Its efficacy is similar to that of imipramine (20 mg/kg), used as the positive standard.
| Animal Model: |
Male Wistar rats (200 ± 250 g).
|
| Dosage: | IP or PO. |
| Administration: | 0.3, 1 and 10 mg/kg, i.p. (Conflict drinking test). |
| Result: | At a dose of 0.3 mg/kg was not ffective, at doses of 1 and 10 mg/kg i.p. significantly (F (3,30)=11.193, P<0.001), increased the number of shocks (by 330 and 507%, respectively) accepted during the experimental session in the Vogel test. |
| Animal Model: |
Male Wistar rats (200 ± 250 g).
|
| Dosage: | IP or PO. |
| Administration: | 1, 3 and 10 mg/kg, i.p. or 10 and 30 mg/kg, p.o.(Elevated plus-maze test). |
| Result: |
Administered at a dose of 1 mg kg71 i.p. did not change the entries into and time spent in the open arms. At doses of 3 and 10 mg/kg i.p. significantly (F (3,24)=22.978, P<0.001) dose-dependently increased the time spent in the open arms (up to 45 and 74%, respectively), and the percentage of entries into the open arms (up to 48 and 68%, respectively, F(3,24)=5.678, P<.01 at doses of and mg i.p. significantly increased the total number entries reduced about time spent not shown in arms type>
At the dose of 30 mg/kg (po, but not 10 mg/kg) significantly (up to 64%, F (2,16)=14.249, P<0.001) increased the percentage of the time spent in the open arms and the percentage of entries into the open arms (up to 63%, F (2,16)=7.295, P<0.01). MPEP given p.o. in both doses used did not change the total number of entries nor the total time spent in the arms (either type).
|
2-甲基-6-(苯基乙炔基)吡啶盐酸盐 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-06-05 | HY-14609R | 2-甲基-6-(苯基乙炔基)吡啶盐酸盐 | 219911-35-0 | 5 mg | 660 |
| 2026-06-05 | HY-14609R | 2-甲基-6-(苯基乙炔基)吡啶盐酸盐 | 219911-35-0 | 10 mg | 1060 |
